Amicus (FOLD) has resolved the patent litigation it brought in response to Aurobindo Pharma’s and Lupin Ltd.’s Abbreviated New Drug Applications ...

Laurus Labs shares closed 3.19% higher at Rs 1,047.90 per share, Wockhardt Pharma shares surged 2.36% to close higher at Rs 1 ...

The US Food and Drug Administration (USFDA) inspected Unit-IV of APL Healthcare Ltd., a wholly-owned subsidiary of the ...

All constituents on the Nifty Pharma index are trading with gains, led by Wockhardt, which is trading with gains of over 6.5% ...

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) concluded the ...

Aurobindo Pharma Ltd. is an integrated pharmaceutical company that delivers innovative solutions. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. Its robust ...

Aurobindo Pharma USA, a subsidiary of Aurobindo Pharma, has entered into a definitive agreement to acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Novartis has its U.S. generics sale. After shopping pieces of its troubled Sandoz business for months, the Swiss drugmaker has unloaded a big chunk—including some easy-to-copy generics and several ...

Four pharma stocks to watch today as Lupin signs a peptide API deal, Dr Reddy’s and Aurobindo face FDA observations, and ...

This initiative is part of Aurobindo Pharma’s broader strategy to strengthen its presence in international markets, particularly in the pharmaceutical sector. HYDERABAD, India — Aurobindo Pharma ...

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market ...

Hyderabad, India. (6th September, 2010) - Aurobindo Pharma is pleased to announce that it has entered into licensing and supply agreements with AstraZeneca, one of the world's leading ...